Skip to content

Artisan Bio news and events

See how Artisan Bio advances the world of custom cells. Because the best cells make the best cures.


Cabaletta Bio and Artisan Bio Announce Gene Editing Research and Collaboration Agreement to Develop Next-Generation CAAR T Cell Therapies

PHILADELPHIA and DENVER, July 7, 2020 — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, and Artisan Bio, Inc., a precision cell therapy engineering company, today announced they have signed a research and collaboration agreement to…

Photo by Drew Hays on Unsplash

Artisan Bio Announces Global Research and Discovery Collaboration Agreement with Takeda to Develop Next-Generation Cell Therapy Products

Denver, Colorado – Jan 15, 2020 – Artisan Bio, Inc., a stealth cell therapy engineering company, today announced it has entered into a global research and collaboration agreement with Takeda Pharmaceutical Company Limited (“Takeda”) for the discovery, development, and commercialization of novel cell therapy products. “Many limitations that exist in current generation cell therapies can…